Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HYAL1 antibody (N-Term)

The Rabbit Polyclonal anti-HYAL1 antibody has been validated for WB and IHC and has been independently validated. It is suitable to detect HYAL1 in samples from Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse and Rabbit.
Catalog No. ABIN2784342

Quick Overview for HYAL1 antibody (N-Term) (ABIN2784342)

Target

See all HYAL1 Antibodies
HYAL1 (Hyaluronidase-1 (HYAL1))

Reactivity

  • 64
  • 12
  • 12
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit

Host

  • 66
  • 8
  • 1
Rabbit

Clonality

  • 70
  • 5
Polyclonal

Conjugate

  • 43
  • 6
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HYAL1 antibody is un-conjugated

Application

  • 50
  • 37
  • 17
  • 17
  • 14
  • 13
  • 13
  • 9
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Binding Specificity

    • 15
    • 9
    • 5
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    N-Term

    Sequence

    WNANTQWCLE RHGVDVDVSV FDVVANPGQT FRGPDMTIFY SSQLGTYPYY

    Predicted Reactivity

    Cow: 83%, Dog: 86%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 93%, Rat: 100%

    Characteristics

    This is a rabbit polyclonal antibody against HYAL1. It was validated on Western Blot using a cell lysate as a positive control.

    Purification

    Affinity Purified

    Immunogen

    The immunogen is a synthetic peptide directed towards the N terminal region of human HYAL1
  • Application Notes

    Optimal working dilutions should be determined experimentally by the investigator.

    Comment

    Antigen size: 405 AA

    Restrictions

    For Research Use only
  • Validation #100030 (Western Blotting)
    'Independent Validation' Badge
    by
    University of Manitoba, Max Rady College of Medicine Biochemistry and Medical Genetics, Department of Biochemistry and Medical Genetics
    No.
    #100030
    Date
    07/05/2016
    Antigen
    HYAL1 antibody - N-terminal region
    Lot Number
    QC25700
    Method validated
    Western Blotting
    Positive Control
    Hyal1 +/+ mouse liver lysates, Hyal1 -/- mouse embryonic fibroblasts liver lysates overexpressing human HYAL1
    Negative Control
    Hyal1 -/- mouse liver lysates, Hyal1 -/- mouse embryonic fibroblasts
    Notes
    ABIN2784342 detects endogenous mouse HYAL1, and overexpressed human HYAL1 by Western blot analysis. The positive western blot assessment is based on the detection of a band of the appropriate molecular mass in Hyal1+/+ but not Hyal1-/- mouse tissue and the presence of a band of the appropriate molecular mass in Hyal1-/- cells transfected with human HYAL1. The identify of these bands was confirmed using the 1D10 antibody that had previously been shown to detect HYAL1. There are background bands to be considered in the interpretation of the blot.
    'Independent Validation' Badge
    Validation Images
    Full Methods
    Primary Antibody
    ABIN2784342
    Secondary Antibody
    Peroxidase AffiniPure Donkey Anti-Rabbit IgG (H+L) (Jackson Labs, 711-035-152, Lot 106483)
    Full Protocol
    • Overexpression of human HYAL1:
      • The Human HYAL1 cDNA was cloned into an overexpressed vector and transiently transfected in mouse embryonic fibroblasts (MEFs) deficiency in HYAL1.
    • Mouse Sample Preparation:
      • Liver from Hyal1 knockout mice harvested along with that from a wildtype control was stored at -80°C until used.
      • Liver pieces were weighed and placed in tubes containing 1.5ml of cold imidazole buffer pH7.4 containing 250mM sucrose with added protease inhibitors (Sigma).
      • The tissues were homogenized by Polytron (Kinematica, PT10-35, two rounds of 5s at a setting of 6) with the tubes partially submerged in an ice bath to keep samples cold.
      • The homogenized samples were centrifuged at 600xg for 10min to remove nuclei and intact cells.
      • The post-nuclear supernatant was centrifuged at 100000xg for 1h.
      • The resulting supernatant and resuspended pellet were measured in a Bradford assay for (Bio-Rad, 500-0006).
      • Samples were boiled for 5min in SDS PAGE buffer including DTT as reducing reagent.
      • Preliminary Western blot experiments with anti-Hyal1 (1D10) (hybridoma supernatant diluted 1:25) showed Hyal1 could specifically be detected in the 100000xg supernatant fraction of wildtype liver samples.
      • This fraction was used for testing the other Hyal1 antibodies.
    • Western blotting:
      • Aliquots of the 100000xg supernatant fraction of wildtype liver sample corresponding to 30µg total protein were separated by SDS PAGE (7.5% gel) on Bio Rad II electrophoresis units.
      • The separated proteins were transferred using Tris-glycine buffer (25mM tris, 192mM glycine pH8.3) for 1h at 100V to nitrocellulose membrane (Bio-Rad, 162-0112) using a Bio-Rad Trans-blot cell.
      • Transfer quality was assessed by Ponceau S (0.1% in 3% acetic acid).
      • Transfers were blocked with 5% non-fat milk in TBST (tris buffered saline + 0.1% Tween 20 pH7.4) for 1h at RT.
      • Incubation with ABIN2784342 (1µg/ml) in 5ml in blocking buffer overnight at 4°C.
      • Membranes were washed 3x 10min with TBST.
      • Incubation with donkey-anti-rabbit secondary antibody conjugated to HRP (Jackson Labs, 711-035-152, Lot 106483) diluted 1:15000 in blocking buffer) for 1h at RT.
      • Transfers were washed 3x 10min in TBST at RT.
      • Transfers were washed 2x with H2O.
      • Bands were visualized by incubation for 5min with Immobilon Western HRP Substrat (Millipore, WBKLS0500, lot 1530902).
      • Image capture was carried on film (Kodak BioMax film for chemiluminescence) or digitally on a ChemiDoc (Bio-Rad).
    Experimental Notes
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Target

    HYAL1 (Hyaluronidase-1 (HYAL1))

    Alternative Name

    HYAL1

    Background

    HYAL1 is a lysosomal hyaluronidase. Hyaluronidases intracellularly degrade hyaluronan, one of the major glycosaminoglycans of the extracellular matrix. Hyaluronan is thought to be involved in cell proliferation, migration and differentiation. This enzyme is active at an acidic pH and is the major hyaluronidase in plasma. Mutations in HYAL1 are associated with mucopolysaccharidosis type IX, or hyaluronidase deficiency. HYAL1 is one of several related genes in a region of chromosome 3p21.3 associated with tumor suppression. Multiple transcript variants encoding different isoforms have been found for HYAL1.This gene encodes a lysosomal hyaluronidase. Hyaluronidases intracellularly degrade hyaluronan, one of the major glycosaminoglycans of the extracellular matrix. Hyaluronan is thought to be involved in cell proliferation, migration and differentiation. This enzyme is active at an acidic pH and is the major hyaluronidase in plasma. Mutations in this gene are associated with mucopolysaccharidosis type IX, or hyaluronidase deficiency. The gene is one of several related genes in a region of chromosome 3p21.3 associated with tumor suppression. Multiple transcript variants encoding different isoforms have been found for this gene.
    Alias Symbols: HYAL-1, LUCA1, MGC45987, NAT6
    Protein Interaction Partner: UBC, COL2A1,
    Protein Size: 405

    Molecular Weight

    45 kDa

    Gene ID

    3373

    NCBI Accession

    NM_153282, NP_695014

    UniProt

    Q12794

    Pathways

    Glycosaminoglycan Metabolic Process
You are here:
Chat with us!